An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Klisyri

Chemical Nametirbanibulin
Dosage FormOintment (topical; 1%)
Drug ClassInhibitors
SystemSkin
CompanyAlmirall, LLC
Approval Year2020

Indication

  • For the topical treatment of actinic keratosis of the face or scalp
Last updated on 12/18/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Klisyri (tirbanibulin) Prescribing Information. 2020Almirall, LLC Exton, PA
Document TitleYearSource
A phase 3, double-blind, vehicle-controlled, randomized, parallel group, multicenter, efficacy and safety study of KX2-391 ointment 1% in adult subjects with actinic keratosis on the face or scalp (AK003). 2020Athenex, Inc.
A phase 3, double-blind, vehicle-controlled, randomized, parallel group, multicenter, efficacy and safety study of KX2-391 ointment 1% in adult subjects with actinic keratosis on the face or scalp (AK004). 2020Athenex, Inc.